Tebentafusp-tebn (Kimmtrak)
Dilution requiredFull monograph review pending
U.S. label preparation
Kimmtrak · Dilution required
- Preparation
- Prepare the 100 mL 0.9% sodium chloride bag with human albumin to 250 mcg/mL before adding drug. The albumin prevents adsorption.
- Administration and handling
- Use Table 2 for the volume of the available albumin strength and the label's dose-specific drug volume. Use the specified filter and monitoring.
Product and source details
Immunocore Commercial LLC · BLA761228
Product NDC: 80446-401
SPL effective 2026-08-20 | SPL version 9. Checked 2026-11-13.
Source for this summary: U.S. prescribing information. Use the full label for dose selection, contraindications, preparation tables and monitoring.
Product identifiers and clinical review status
U.S. label preparation available. Full monograph review pending.
Exact formulation, concentration, container, manufacturer, regulatory identifiers, and a reproducible label snapshot have not all been reconciled.
What remains to be completed
- Obtain independent corroboration of the label preparation where available.
- Complete indication- and age-specific dosing, incompatibility, monitoring and stability review.
- Assess any proposed compounding BUD for the exact formulation, concentration, container and conditions.